FDA Approves Marketing of Plant-Derived Marijuana Medicine
FDA Approves Marketing of Plant-Derived Marijuana Medicine
FDA Approves Marketing of Plant-Derived Marijuana Medicine | NORML
WASHINGTON, DC — Regulators at the US Food and Drug Administration on Monday granted market approval for Epidiolex, a prescription medicine containing a standardized formulation of plant-derived cannabidiol (CBD), for the explicit treatment of two rare forms of severe epilepsy: Lennox-Gastaut syndrome and Dravet syndrome. The FDA’s decision was not unexpected, as the proprietary extract formulation — developed by the […]
FDA Approves Marketing of Plant-Derived Marijuana Medicine | The Daily Chronic
Go to Source
Powered by WPeMatico